Rise in Prevalence of Obesity in Youth, Adults With T1DM Seen From 2008 to 2023
By Elana Gotkine HealthDay Reporter
FRIDAY, April 4, 2025 -- From 2008-2011 to 2020-2023, there was an increase in the prevalence of obesity among youth and adults with type 1 diabetes, and glucagon-like peptide 1 receptor agonist (GLP-1 RA) prescriptions also increased for this group over time, according to a study published online March 3 in Diabetes, Obesity and Metabolism.
Yunwen Xu, Ph.D., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues characterized trends in obesity and prescriptions for GLP-1 RAs across body mass index (BMI) categories among U.S. patients with type 1 diabetes (youth [2 to 19 years] and adults [20 years and older]).
The researchers found that from 2008-2011 to 2020-2023, the prevalence of obesity increased from 18.1 to 26.0 percent among youth with type 1 diabetes and from 30.5 to 38.1 percent for adults with type 1 diabetes. Black and Hispanic youth and adults had the highest obesity rates; over time, racial and ethnic disparities persisted. Across all BMI categories, GLP-1 RA prescriptions increased significantly during the last 15-year period in a dose-response manner among youth and adults with type 1 diabetes.
"Obesity and GLP-1 RA prescriptions across different BMI categories have surged over the last 15-year period in a large and diverse U.S. population of youth and adults with type 1 diabetes," the authors write. "Our findings underscore the urgent need for safety and efficacy data on GLP-1 RAs and clinical guidelines for obesity management among the type 1 diabetes population."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
Endocrine Society, July 12-15
The annual meeting of the Endocrine Society (ENDO 2025) was held from July 12 to 15 in San Francisco, attracting more than 7,000 participants, including clinicians, academicians...
Prevalence of Extremely Severe Obesity Increasing in Children
TUESDAY, July 22, 2025 -- From 2008 to 2023, there was an increase in the prevalence of extremely severe obesity in children, especially among older adolescents and non-Hispanic...
Long-Term Obesity Linked to Expression of Aging Biomarkers
THURSDAY, July 17, 2025 -- Long-term obesity is associated with the expression of biomarkers denoting antagonistic and integrative aging hallmarks in adults aged 28 to 31 years...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.